Issue 4/2009
Content (14 Articles)
Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer
Tianqian Zhang, Dorothee Herlyn
Intravesical administration of γδ T cells successfully prevents the growth of bladder cancer in the murine model
Takeshi Yuasa, Kiyoshi Sato, Eishi Ashihara, Miki Takeuchi, Shinya Maita, Norihiko Tsuchiya, Tomonori Habuchi, Taira Maekawa, Shinya Kimura
Antigen-presenting cells containing multiple costimulatory molecules promote activation and expansion of human antigen-specific memory CD8+ T cells
Sixun Yang, Jeffrey Schlom
Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma
Robin Goforth, Aliasger K. Salem, Xiaoyan Zhu, Suzanne Miles, Xue-Qing Zhang, John H. Lee, Anthony D. Sandler
Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor
Mariangela Figini, Franck Martin, Renata Ferri, Elena Luison, Elena Ripamonti, Alberto Zacchetti, Mimosa Mortarino, Vito Di Cioccio, Giovanni Maurizi, Marcello Allegretti, Silvana Canevari
Early developmental expression of a normally tumor-associated and drug-inhibited cell surface-located NADH oxidase (ENOX2) in non-cancer cells
NaMi Cho, D. James Morré
A fast and efficient HLA multimer-based sorting procedure that induces little apoptosis to isolate clinical grade human tumor specific T lymphocytes
Régis Bouquié, Annabelle Bonnin, Karine Bernardeau, Amir Khammari, Brigitte Dréno, Francine Jotereau, Nathalie Labarrière, François Lang
Interferon regulatory factor 8 mediates tumor-induced inhibition of antigen processing and presentation by dendritic cells
Irina L. Tourkova, Galina V. Shurin, Soldano Ferrone, Michael R. Shurin
NK1.1+ cells mediate the antitumor effects of a dual Toll-like receptor 7/8 agonist in the disseminated B16-F10 melanoma model
Calin D. Dumitru, Mary A. Antonysamy, Kevin S. Gorski, Dave D. Johnson, Laxma G. Reddy, Jody L. Lutterman, Melissa M. Piri, Joel Proksch, Sean M. McGurran, Elaine A. Egging, Felicia R. Cochran, Kenneth E. Lipson, Mark A. Tomai, Gary W. Gullikson
Treatment of ovarian cancer cell lines with 5-aza-2′-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules
Sara J. Adair, Kevin T. Hogan
High expression of PGE2 enzymatic pathways in cervical (pre)neoplastic lesions and functional consequences for antigen-presenting cells
Michaël Herfs, Ludivine Herman, Pascale Hubert, Frédéric Minner, Mohammad Arafa, Patrick Roncarati, Yves Henrotin, Jacques Boniver, Philippe Delvenne
Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse
Alain P. Vicari, Rachel Luu, Ningli Zhang, Shobhna Patel, Shawn R. Makinen, Douglas C. Hanson, Risini D. Weeratna, Arthur M. Krieg
In vivo anti-melanoma efficacy of allo-restricted CTLs specific for melanoma expanded by artificial antigen-presenting cells
Xiao-ling Lu, Xiao-bing Jiang, Ru-en Liu, Sheng-min Zhang
In vivo anti-melanoma efficacy of allo-restricted CTLs specific for melanoma expanded by artificial antigen-presenting cells
Xiao-ling Lu, Xiao-bing Jiang, Ru-en Liu, Sheng-min Zhang, Zhi-hui Liang